Navigation Links
NYU study compares consequences of teen alcohol and marijuana use
Date:9/2/2014

" said Dr. Palamar. "Compared to non-drinkers, frequent drinkers were over 13 times more likely to report that their alcohol use has led to unsafe driving. Marijuana users, compared to non-users, were three times more likely to report unsafe driving as a direct result of use."

The researchers also found that alcohol use was more commonly reported to compromise relationships with friends and significant others (e.g., boyfriends); it was also reported to lead to more regret, particularly among females. Marijuana use on the other hand was more commonly reported to compromise relationships with teachers or supervisors, result in less energy or interest, and result in lower school or job performance.

Females in particular were more likely to report engaging in behaviors they regretted after using alcohol. They were also more likely than males to report feeling less emotionally stable, and not being able to think as clearly due to alcohol use. White students were more likely to report various adverse outcomes resulting from alcohol use such as engaging in behavior that one regrets, inability to think clearly, and driving unsafely. Interestingly, researchers found that both frequent and infrequent marijuana users were more likely to report no adverse outcomes associated with marijuana use.

"Not unexpectedly, we found that the higher the frequency of use, the higher the risk of reporting an adverse outcome," said Dr. Palamar. "In particular, the relationship between frequent alcohol use and regret was much stronger than the relationship between frequent marijuana use and regret."

Overall, females were at higher risk for reporting the majority of adverse outcomes assessed by MTF. Racial or ethnic minorities (most often black students) were at decreased risk for many adverse outcomes, and this "protective" effect tended to be more pronounced for alcohol than marijuana.

The researchers found that marijuana users are more like
'/>"/>

Contact: Christopher James
christopher.james@nyu.edu
212-998-6876
New York University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Family Meals May Defuse Cyberbullyings Impact, Study Says
2. Early Stage Minimally Invasive Candidate AD Biomarkers Reviewed in New Study by Biopharm Reports Available at MarketPublishers.com
3. Operating Room Equipment Market Study 2019 by Transparency Market Research
4. NutriGold Highlights New Study on the Importance of Vitamin D to Our Life Span
5. Doctor-Shopping for Painkillers Common After Broken-Bone Surgery, Study Finds
6. Mice study shows efficacy of new gene therapy approach for toxin exposures
7. Study reveals how Ebola blocks immune system
8. Study Counters Critics of Plainer Cigarette Packaging
9. European MRSA Originated in Sub-Saharan Africa, Study Finds
10. European Study Says Disease Progression Predicts Mesothelioma Survival Better Than Treatment Response, According to Surviving Mesothelioma
11. UHY Study Shows Bank Lending In USA Falling Behind G7 Peers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... TX (PRWEB) June 01, 2015 Carson ... to facilitate their investors IRA transactions. AdvantaIRA Trust, LLC ... Giving investors the ability to fund positions using IRA’s ... to participate on a project, even if there current ... Provide an additional funding source for Carson and their ...
(Date:6/1/2015)... York (PRWEB) June 01, 2015 The ... ) has amended the Case Management Order governing ... testosterone gel. The Amended Order which was issued ... on May 29, 2015, directs the parties to submit ... August 10, 2015 that outlines parameters and the process ...
(Date:6/1/2015)... TREE, CO (PRWEB) June 01, 2015 ... announce they have been named an Ultherapy® ... Atagi Plastic Surgery and Skin Aesthetics is one of ... Ulthera as a premier treatment provider. , Atagi ... Ultherapy in the Denver area has led the practice ...
(Date:6/1/2015)... 2015 Linda Kincaid, age 67, knew something ... heartbeat. At first she thought it was just a part ... much more than that. After going to the doctor, she ... felt afraid about what might happen to her. , Linda ... diagnosed with valve disease each year. Valve disease involves damage ...
(Date:6/1/2015)... 01, 2015 On May 14, 2015, ... center hosted the Cherry Creek Chamber of Commerce for ... Urgent care centers typically do not offer primary care ... Express Cherry Creek Urgent Care staff to schedule family ... From 5:30 to 7:30 p.m. the center hosted presidents, ...
Breaking Medicine News(10 mins):Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 3Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 4Health News:Atagi Plastic Surgery and Skin Aesthetics Named Ultherapy® Ultra Treatment Provider 2Health News:A New Online Resource for Those Living with Heart Valve Disease 2Health News:A New Online Resource for Those Living with Heart Valve Disease 3Health News:Grand Opening For AFC/Doctors Express Cherry Creek Primary Care Clinic 2
... Dental Laser Market, SAN CLEMENTE, Calif., Feb. ... Inc. (Nasdaq: BLTI ) announced the,formation of ... laser,division, Lasers4Dentistry, and a laser therapy division,Technology4Therapy. Jeffrey ... and Keith G. Bateman, Biolase,s former Executive Vice ...
... Va., Feb. 21 Federal Health Information,Technology (IT) spending ... $4.5,billion in 2013 at a compound annual growth rate ... IT market, according to a new report by,INPUT, the ... robust, several things remain in the way of even,more ...
... and Water Reuse are Honored, NEW ... curricular solution for pharmacy education, has been,awarded ... Electronic Publication or,Product from the Professional/Scholarly Publishing ... In addition, the McGraw-Hill,reference, Water Reuse: Issues, ...
... release is available in Spanish . , ... Country, Maria Luisa de Francisco Maiz provided a clinical-forensic evaluation ... that influence the length of legal time periods. , Brain ... only for their high incidence but also because they mainly ...
... There are numerous antidepressant medications currently on ... the debilitating symptoms of depression even with treatment. ... 15th issue of Biological Psychiatry set out to ... serotonin and norepinephrine reuptake inhibitors (SNRIs), like venlafaxine ...
... . , Ikerlan-IK4 (CIC microGUNE Microfluidics Unit - ... device that enables the verification of the optimum conditions for ... a microelectrode that measures the impedance and temperature of the ... be monitored from the moment of its extraction, during its ...
Cached Medicine News:Health News:Former Biolase CEO & EVP Launch Technology4Medicine 2Health News:Federal Health IT Market to Reach $4.5 Billion by 2013 2Health News:McGraw-Hill Professional Products Win Awards From Association of American Publishers 2Health News:Guidelines for evaluation of psychological side-effects of brain injury 2Health News:Guidelines for evaluation of psychological side-effects of brain injury 3Health News:Comparison of venlafaxine and SSRIs in the treatment of depression 2Health News:A device that measures optimum state of an organ prior to transplanting has been patented 2
(Date:6/1/2015)... Columbia and MENLO PARK, ... DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" ... developing and commercializing proven cancer therapies in new ... from its Phase I/II clinical trial of  VAL-083 ... the most common and deadly form of human ...
(Date:6/1/2015)... , June 1, 2015 CEFALY ... electrical nerve stimulation device specifically authorized for use prior ... data from a new PET trial showing that the ... in the brain in migraine patients, namely the orbitofrontal ... Tomography (PET) scan, which is an imaging test of the brain, used ...
(Date:6/1/2015)... June 1, 2015  Boston Biomedical, an industry leader ... cancer stem cell (CSC) pathways, will present clinical data ... multiple tumor types at the 2015 American Society of ... . Data presented at ASCO highlight ... that targets STAT3, leading to inhibition of the critical ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 2DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 4DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 5DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 6DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 7DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 8New Study Shows CEFALY Returns Normal Metabolic Activity to Brain Areas in Migraine Patients 2Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 2Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 3Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 4Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 5Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 6Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 7
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: